EntryPoint Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$820K Sell
8,113
-3,862
-32% -$400K 0.2% 133
2026
Q1
$1.16M Buy
+11,975
New +$1.23M 0.34% 30
2025
Q4
Sell
-3,679
Closed -$467K 713
2025
Q3
$467K Buy
+3,679
New +$438K 0.18% 187
2024
Q3
Sell
-435
Closed -$37.3K 822
2024
Q2
$37.3K Buy
435
+290
+200% +$24.3K 0.02% 1147
2024
Q1
$12K Buy
+145
New +$10.6K 0.01% 1205

Other funds holding EHC

EntryPoint Capital's EHC Position: Q2 2026 in Review

EntryPoint Capital reduced its Encompass Health (EHC) stake by 32% in Q2 2026, selling an estimated $400K and leaving 8,113 shares worth $820K. The position accounts for 0.2% of the portfolio, ranked #133.

EntryPoint Capital first reported a position in EHC in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.16M in Q1 2026. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • EntryPoint Capital held 8,113 shares of Encompass Health worth $820K as of Q2 2026.
  • EntryPoint Capital sold 3,862 Encompass Health shares in Q2 2026, an estimated $400K.
  • Encompass Health made up 0.2% of EntryPoint Capital's portfolio in Q2 2026, its #133 holding.
  • EntryPoint Capital first reported a position in Encompass Health in Q1 2024 and has held it in 5 quarters since.
  • EntryPoint Capital's Encompass Health position peaked at $1.16M in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.